$13.13
0.100.77%
Last update: Nov 11, 4:00 PM
Medifast Inc
MEDNYSE
Medifast rose 12.7% from $11.65 to $13.13, ahead of the S&P 500's +9.8%. Its worst day was Jul 22 (−7.2%), and its low came Jul 23 at $9.45.
Nov 11, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.55 beat the $-0.80 estimate on $75.1M revenue (est. $71.2M); FY revenue guidance of $270.0M–$300.0M against the $355.1M consensus.
−0.8% · S&P 500 +0.5%
Story events cover the past 12 months · Times ET
EPS of $-0.19 beat the $-0.53 estimate on $76.0M revenue (est. $70.1M); FY revenue guidance of $270.0M–$300.0M against the $275.3M consensus.
+22.5% · S&P 500 +0.8%
Medifast closed at its lowest level of the year, 18.9% below where the year started.
−3.2% · S&P 500 −1.2%
EPS of $-0.28 beat the $-0.66 estimate on $76.4M revenue (est. $73.8M); FY revenue guidance of $270.0M–$300.0M against the $281.0M consensus.
+34.3%, the year's best day · S&P 500 +1.8%
EPS of $-0.19 beat the $-0.36 estimate on $72.0M revenue (est. $70.6M); FY revenue guidance of $280.0M–$300.0M against the $286.2M consensus.
+2.0% · S&P 500 +0.7%
Where it ended: a close of $13.13 on Nov 11, 2026. Up next: Q4 2026 earnings on Feb 16, 2027 (EPS est. $0.03, revenue est. $63.3M).
Nothing in the past 12 months.
All MED dividend historyAs of the Nov 11, 2026 close
Replay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for MED and SPY from Benzinga historical bars. Not investment advice.
